ReviewDrug design, development and therapy2023

Research Progress on the Efficacy and Safety of Spironolactone in Reversing Left Ventricular Hypertrophy in Hemodialysis Patients.

Zuoya Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.